Search

everythinglearnresearchcommunity

for

Search:↓

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Thymosin β4 helps with healing, inflammation, and organ protection.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

EGFR and mTOR inhibitors may help manage Olmsted syndrome symptoms.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

The new assay can help develop products for hair re-growth.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Bupropion may help treat trichotillomania when fluoxetine doesn't work.

Cabergoline is more effective and has fewer side effects than bromocriptine for treating women with hyperprolactinemic amenorrhea.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

A synthetic octapeptide may help promote hair growth and counteract hair loss.

Cyproterone acetate can effectively treat idiopathic hirsutism, but ethinyl oestradiol and lynoestrenol may not always reduce hair growth.

GLP-1 receptor agonists may cause hair loss, but regrowth is rare.

Melatonin-loaded nanoparticles improve antidepressant effects and HPA hormone balance better than regular melatonin.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

G-1 promotes hair growth in female mice by activating specific signaling pathways.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

Pharmacophore models can predict liver toxicity and central nervous system toxicity, but they have limitations and specific requirements.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Prolactin may influence skin glands and could be a target for treating acne and skin aging.

GLP-1RAs may cause hair loss but could also help regrow hair in some cases.

Euph E and Euri A from Euphorbia neriifolia help control inflammation and immune response in cells.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Spironolactone helped reduce excessive facial hair in a woman with porphyria cutanea tarda.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.